search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


The functional added value of microprocessor-controlled knee joint for amputees over the age of 65, a pilot study


- candidate number27256
- NTR NumberNTR6456
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR7-jun-2017
- Secondary IDsNL57678.015.16 ABR number
- Public TitleThe functional added value of microprocessor-controlled knee joint for amputees over the age of 65, a pilot study
- Scientific TitleThe functional added value of microprocessor-controlled knee joint for amputees over the age of 65, a pilot study
- ACRONYMKENEVO-trial
- hypothesisIt is hypothesized that everyday activities could be performed more independently and safely with the Kenevo knee joint than with their existing prosthetic knee joint for elderly patients who have undergone an above-knee amputation or knee disarticulation in the past, and who suffer limited activity in and around the house.
- Healt Condition(s) or Problem(s) studiedAmputees
- Inclusion criteriaIn order to be eligible to participate in this study, a subject must meet all of the following criteria:
o Age 65 years and older.
o Unilateral above-knee amputation or knee disarticulation.
o Have completed an active rehabilitation program in the past
o Wearing prosthesis.
o Comfortable walking speed between 0.2-0.8 m/s
o Limited activity in and around the house.
- Exclusion criteriaA potential subject who meets any of the following criteria will be excluded from participation in this study:
o Additional severe orthopaedic, rheumatologic or neurological impairments that may impede gait-related performance.
o Severe perceptual or cognitive impairments.
o Lack of understanding of the Dutch language (in view of e.g. questionnaires used).
- mec approval receivedyes
- multicenter trialno
- randomisedyes
- masking/blindingSingle
- controlActive
- groupCrossover
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 16-feb-2017
- planned closingdate30-jun-2017
- Target number of participants10
- InterventionsThe intervention used is a microprocessor-controlled prosthetic knee joint, called Kenevo (Otto Bock GmbH, Vienna, Austria), developed for geriatric amputees.
- Primary outcomeActual level of independence in everyday life activities will be evaluated with the ‘The Assessment of Daily Activity Performance in Transfemoral amputee test’ (ADAPT). The ADAPT objectively measures functional performance in time (seconds, s) in daily life. Timepoints: baseline and at 1, 2, 14, 15, 16 and 28 weeks
- Secondary outcome• Locomotor Capabilities Index (LCI), timepoints: baseline and at 1, 2, 14, 15, 16 and 28 weeks.
• 2 minute walk test (2MWT), timepoints: baseline and at 1, 2, 14, 15, 16 and 28 weeks.
• Needs and Provision Complexity Scale (NPCS), timepoints: baseline and at 14 and 28 weeks.
• Prosthetic Limb Users Survey of Mobility (PLUS-M), timepoints: baseline and at 14 and 28 weeks.
• Activity-specific Balance Confidence Scale (ABC), timepoints: baseline and at 14 and 28 weeks.
• Falls Efficacy Scale International (FES-1), timepoints: baseline and at 14 and 28 weeks.
• Patient’s diary: daily during two periods of 12 weeks when patient is at home.
- Timepointsbaseline and at 1, 2, 14, 15, 16 and 28 weeks
- Trial web site
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIESMD PhD Bea Hemmen
- CONTACT for SCIENTIFIC QUERIESMD PhD Bea Hemmen
- Sponsor/Initiator Adelante Zorggroep, Department Center of Expertise of Rehabilitation and Audiology
- Funding
(Source(s) of Monetary or Material Support)
Otto Bock Healthcare Products GmbH
- Publications
- Brief summaryRationale/Objective:
The number of elderly people in the Netherlands is growing and will grow further in the future, mainly because of increased life expectancy. This is particularly true for the province of Limburg. Older people value being able to live independently for as long as possible, but this requires good health. In recent decades, the health of the elderly has improved greatly, particularly in regard to cardiovascular care. This has meant that patients with severe peripheral vascular disease undergo amputation later in life. The total number of these patients are increasing. The treatment for these patients is primarily medical support by geriatricians and treatment using therapies and aids by a rehabilitation physician/team. The development of tools such as leg prostheses has accelerated. In the last few decades, computer-controlled knee prostheses have been designed for active younger patients with a leg amputation. Recently, this technology has also been used in a knee prosthesis for older patients. Research indicates that the prosthesis leads to improved impairment levels (gait parameters such as step length), but so far no research has been done on improving activity and participation levels, which better reflect the patient’s daily life. “Activities” refers to aspects of a person’s actions, such as self-care, standing, walking and participation that underpin their participation in social life (work, hobbies, exercise). To summarise, the problem addressed in this study is whether geriatric amputees can be more independent in their everyday life activities if their prosthesis is optimised by using a microprocessor-controlled prosthetic knee joint with specific biomechanical properties aimed at specifically supporting everyday movements. The aim of this pilot study is to see to what extent elderly transfemoral or knee-disarticulated amputees are more independent in their everyday life activities if they use a Kenevo knee joint instead of their current one.

Study design:
This pilot study is a randomised crossover repeated measures study.

Study population:
Ten patients of at least 65 years with an unilateral transfemoral amputation or knee disarticulation in the past followed by a rehab programme, who have a comfortable walking speed of 0.2-0.8 m/s.

Intervention:
A microprocessor-controlled prosthetic knee joint, called Kenevo, specifically developed for elderly amputees.

Main study parameter/endpoint:
Actual level of independence in everyday life activities. This will be measured using the Assessment of Daily Activity Performance in Transfemoral amputee test.

- Main changes (audit trail)
- RECORD7-jun-2017 - 1-jul-2017


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl